During the past decade, Matsudo City General Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Matsudo City General Hospital" #1 sponsor was "Bayer" with 2 trials, followed by "Janssen Research & Development, LLC" with 2 trials sponsored, "Chiba University" with 1 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Matsudo City General Hospital" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Matsudo City General Hospital" are "Uterine Fibroids" (2 trials), "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis" (1 trials), "Arthroplasty, Replacement, Knee" (1 trials), "Chronic Pain" (1 trials) and "Microscopic Polyangiitis" (1 trials). Many other conditions were trialed in "Matsudo City General Hospital" in a lesser frequency.

Most popular intervention types in "Matsudo City General Hospital" are "Drug" (7 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Vilaprisan (BAY1002670)" (2 trials), "Apixaban 2.5 mg" (1 trials), "Apixaban placebo" (1 trials) and "Baricitinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Matsudo City General Hospital" are 5 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Matsudo City General Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Matsudo City General Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Matsudo City General Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".